Breaking News Instant updates and real-time market news.

CBAY

CymaBay

$6.76

-0.32 (-4.52%)

16:58
06/24/19
06/24
16:58
06/24/19
16:58

CymaBay initiated with a Buy at Stifel

Stifel analyst Derek Archila initiated CymaBay with a Buy rating and $14 price target, saying he believes the company's seladelpar "will ultimately prove efficacious in its Phase 2b NASH study." He added that he sees the recent pullback as a significant buying opportunity.

CBAY CymaBay
$6.76

-0.32 (-4.52%)

06/13/19
SBSH
06/13/19
NO CHANGE
Target $12
SBSH
Buy
CymaBay price target lowered to $12 from $21 at Citi
Citi analyst Joel Beatty lowered his price target for CymaBay Therapeutics to $12 from $21 citing the "disappointing" Phase 2 12-week nonalcoholic steatohepatitis data for seladelpar. However, he believes the value of seladelpar in primary biliary cholangitis plus cash presents upside to the current stock price. In addition, the analyst sees "small but real" potential for an upside surprise from the 52-week NASH biopsy data in Q2 of 2020. As a result, Beatty keeps a Buy rating on CymaBay.
06/12/19
HCWC
06/12/19
NO CHANGE
Target $12
HCWC
Buy
CymaBay price target lowered to $12 from $24 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce halved his price target for CymaBay Therapeutics to $12 from $24 after yesterday's 12-week nonalcoholic steatohepatitis data failed to meet its primary endpoint of a reduction in liver fat content. However, CymaBay also reported seladelpar's effects on "several important" liver enzymes, all of which were highly statistically significant and showed "substantial, dose-dependent improvements," Arce tells investors in a research note. He still belies seladelpar still has a "reasonable chance" of demonstrating histologic NASH resolution and keeps a Buy rating on CymaBay.
06/12/19
06/12/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. NXP Semiconductors (NXPI) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Craig Hettenbach saying he sees relative value in the stock after the shares have underperformed peers by 73% during the last three years. 2. AllianceBernstein (AB) upgraded to Buy from Neutral at Goldman Sachs with analyst Alexander Blostein saying the company's "leading" organic fee growth is not priced into the shares at current levels. 3. Brinker (EAT) upgraded to Outperform from Market Perform at Telsey Advisory. 4. CymaBay (CBAY) upgraded to Strong Buy from Outperform at Raymond James with analyst Steven Seedhouse citing the upside potential he sees following the pullback in the stock. 5. CommScope (COMM) upgraded to Buy from Neutral at Rosenblatt with analyst Ryan Koontz saying "surging" fiber spending ahead of 5G buildouts, led by Verizon (VZ), improves the outlook of select companies in the communications equipment sector. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/12/19
CANT
06/12/19
NO CHANGE
Target $20
CANT
Overweight
CymaBay selloff yesterday brings buying opportunity, says Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle says the selloff yesterday in shares of CymaBay Therapeutics strengthens her conviction and presents a buying opportunity. The 52-week biopsy data in early 2020 "remain very much in play from a scientific perspective, but now with much greater upside potential from a stock perspective," Merle tells investors in a research note. While the analyst found the lack of fat benefit at week 12 surprising, she says her thesis on seladelpar in nonalcoholic steatohepatitis is that there are many biological reasons why the drug could show "strong" 52-biopsy data independent of fat changes. There is undue investor focus on MRI-PDFF, making NASH a "very large piece of optionality early next year," says the analyst. Merle reiterates an Overweight rating on CymaBay with a $20 price target. The stock closed yesterday down 45%, or $5.04, to $6.05.

TODAY'S FREE FLY STORIES

RIO

Rio Tinto

$60.55

-0.2 (-0.33%)

05:04
07/24/19
07/24
05:04
07/24/19
05:04
Downgrade
Rio Tinto rating change  »

Rio Tinto downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MPW

Medical Properties Trust

$17.67

0.12 (0.68%)

05:02
07/24/19
07/24
05:02
07/24/19
05:02
Upgrade
Medical Properties Trust rating change  »

Medical Properties Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTD

Trade Desk

$245.89

-3.31 (-1.33%)

04:59
07/24/19
07/24
04:59
07/24/19
04:59
Downgrade
Trade Desk rating change  »

Trade Desk downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

SNAP

Snap

$14.85

0.71 (5.02%)

04:58
07/24/19
07/24
04:58
07/24/19
04:58
Upgrade
Snap rating change  »

Snap upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

NRDBY

Nordea Bank

$0.00

(0.00%)

04:57
07/24/19
07/24
04:57
07/24/19
04:57
Downgrade
Nordea Bank rating change  »

Nordea Bank downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTBIF

Green Thumb Industries

$0.00

(0.00%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Green Thumb Industries management to meet with Benchmark »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 05

    Sep

USWS

U.S. Well Services

$3.25

-0.09 (-2.69%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
U.S. Well Services management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

JLL

Jones Lang LaSalle

$142.91

3.105 (2.22%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Jones Lang LaSalle management to meet with Mizuho »

Meeting with EVP Monahan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

  • 06

    Aug

LULU

Lululemon

$189.12

1.43 (0.76%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Lululemon management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Sep

AGLE

Aeglea BioTherapeutics

$6.91

-0.05 (-0.72%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Aeglea BioTherapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

JWN

Nordstrom

$29.06

0.3 (1.04%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Nordstrom management to meet with KeyBanc »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

VKTX

Viking Therapeutics

$7.94

-0.28 (-3.41%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Viking Therapeutics management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 08

    Aug

  • 09

    Aug

  • 09

    Sep

04:55
07/24/19
07/24
04:55
07/24/19
04:55
General news
Breaking General news story  »

Week of 7/19 MBA Mortgage…

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Wolfe Research media analyst to hold an group luncheon »

Media & Distribution…

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Stephens architecture analysts to hold analyst/industry conference call nosymbol »

Analysts hold an…

NSSC

Napco Security

$26.27

-0.46 (-1.72%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Napco Security management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 12

    Sep

  • 19

    Sep

ADAP

Adaptimmune

$3.49

-0.18 (-4.90%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Recommendations
Adaptimmune analyst commentary  »

Adaptimmune management to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 29

    Jul

  • 29

    Jul

  • 30

    Jul

  • 31

    Jul

BCPC

Balchem

$99.86

1.94 (1.98%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Balchem management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 01

    Aug

04:55
07/24/19
07/24
04:55
07/24/19
04:55
General news
PMI Composite FLASH â€' Level to be reported at 09:45 »

July PMI Composite FLASH…

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Food & Drug Law Institute to hold a conference »

Intro to Drug, Biologics…

04:55
07/24/19
07/24
04:55
07/24/19
04:55
General news
Breaking General news story  »

Week of 7/19 EIA…

ESTE

Earthstone Energy

$4.65

-0.07 (-1.48%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Earthstone Energy management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

04:55
07/24/19
07/24
04:55
07/24/19
04:55
General news
New Home Sales to be reported at 10:00 »

June New Home Sales will…

TLRD

Tailored Brands

$4.82

-0.325 (-6.32%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Tailored Brands management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

QTNT

Quotient

$10.78

0.31 (2.96%)

04:55
07/24/19
07/24
04:55
07/24/19
04:55
Conference/Events
Quotient management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 05

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.